Raub Brock Capital Management LP Has $1.35 Million Stock Position in Willis Towers Watson PLC (NASDAQ:WLTW)

Share on StockTwits

Raub Brock Capital Management LP reduced its holdings in Willis Towers Watson PLC (NASDAQ:WLTW) by 5.4% in the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 7,000 shares of the financial services provider’s stock after selling 400 shares during the quarter. Raub Brock Capital Management LP’s holdings in Willis Towers Watson were worth $1,351,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in the business. Clean Yield Group purchased a new position in shares of Willis Towers Watson in the second quarter worth about $28,000. Redhawk Wealth Advisors Inc. bought a new stake in Willis Towers Watson during the second quarter valued at approximately $31,000. Private Ocean LLC bought a new stake in Willis Towers Watson during the second quarter valued at approximately $38,000. CSat Investment Advisory L.P. lifted its position in Willis Towers Watson by 251.3% during the second quarter. CSat Investment Advisory L.P. now owns 274 shares of the financial services provider’s stock valued at $53,000 after purchasing an additional 196 shares during the last quarter. Finally, Commonwealth Bank of Australia lifted its position in Willis Towers Watson by 32.8% during the second quarter. Commonwealth Bank of Australia now owns 344 shares of the financial services provider’s stock valued at $63,000 after purchasing an additional 85 shares during the last quarter. Hedge funds and other institutional investors own 92.94% of the company’s stock.

Shares of NASDAQ WLTW opened at $188.09 on Tuesday. The company has a quick ratio of 1.83, a current ratio of 1.83 and a debt-to-equity ratio of 0.51. Willis Towers Watson PLC has a 52 week low of $134.50 and a 52 week high of $200.93. The firm’s fifty day moving average is $193.08 and its 200 day moving average is $187.97. The company has a market cap of $24.26 billion, a price-to-earnings ratio of 19.33, a PEG ratio of 1.63 and a beta of 0.81.

Willis Towers Watson (NASDAQ:WLTW) last issued its earnings results on Wednesday, July 31st. The financial services provider reported $1.78 EPS for the quarter, topping the consensus estimate of $1.76 by $0.02. Willis Towers Watson had a net margin of 9.86% and a return on equity of 13.00%. The company had revenue of $2.05 billion for the quarter, compared to the consensus estimate of $2.06 billion. During the same period in the previous year, the firm earned $1.70 earnings per share. The firm’s revenue for the quarter was up 2.9% on a year-over-year basis. Equities research analysts anticipate that Willis Towers Watson PLC will post 10.93 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, October 15th. Investors of record on Monday, September 30th will be paid a $0.65 dividend. This represents a $2.60 annualized dividend and a dividend yield of 1.38%. The ex-dividend date is Friday, September 27th. Willis Towers Watson’s payout ratio is 26.72%.

WLTW has been the subject of several research analyst reports. SunTrust Banks lifted their target price on shares of Willis Towers Watson from $210.00 to $225.00 and gave the company a “buy” rating in a research report on Thursday, July 11th. They noted that the move was a valuation call. UBS Group lifted their target price on shares of Willis Towers Watson from $202.00 to $220.00 and gave the company a “buy” rating in a research report on Wednesday, July 10th. Wells Fargo & Co reiterated a “buy” rating and set a $220.00 target price on shares of Willis Towers Watson in a research report on Wednesday, July 31st. ValuEngine lowered shares of Willis Towers Watson from a “hold” rating to a “sell” rating in a research report on Wednesday, October 2nd. Finally, Barclays set a $235.00 target price on shares of Willis Towers Watson and gave the company a “buy” rating in a research report on Monday, August 12th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company’s stock. Willis Towers Watson presently has a consensus rating of “Buy” and an average target price of $201.33.

In other Willis Towers Watson news, insider Nicolas Aubert sold 7,592 shares of the business’s stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $195.00, for a total transaction of $1,480,440.00. Following the transaction, the insider now directly owns 5,875 shares of the company’s stock, valued at approximately $1,145,625. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.75% of the stock is owned by insiders.

Willis Towers Watson Profile

Willis Towers Watson Public Limited Company operates as an advisory, broking, and solutions company worldwide. The company's Human Capital and Benefits segment offers actuarial support, plan design, and administrative services for traditional pension and retirement savings plans; plan management consulting, broking, and administration services for health and group benefit programs; and benefits outsourcing services.

Read More: What is a back-end load?

Institutional Ownership by Quarter for Willis Towers Watson (NASDAQ:WLTW)

Receive News & Ratings for Willis Towers Watson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Willis Towers Watson and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Ignis Achieves Market Capitalization of $23.76 Million
Ignis Achieves Market Capitalization of $23.76 Million
United Community Banks  Upgraded at Zacks Investment Research
United Community Banks Upgraded at Zacks Investment Research
AIDUS TOKEN 1-Day Trading Volume Reaches $4,913.00
AIDUS TOKEN 1-Day Trading Volume Reaches $4,913.00
SAGE Therapeutics  Given New $100.00 Price Target at Oppenheimer
SAGE Therapeutics Given New $100.00 Price Target at Oppenheimer
GVC  Shares Cross Above 50 Day Moving Average of $851.59
GVC Shares Cross Above 50 Day Moving Average of $851.59
Energy Resources of Australia  Shares Pass Below 50-Day Moving Average of $0.20
Energy Resources of Australia Shares Pass Below 50-Day Moving Average of $0.20


© 2006-2019 Ticker Report